288 related articles for article (PubMed ID: 16018429)
1. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.
Morgan J; Meltzer MI; Plikaytis BD; Sofair AN; Huie-White S; Wilcox S; Harrison LH; Seaberg EC; Hajjeh RA; Teutsch SM
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):540-7. PubMed ID: 16018429
[TBL] [Abstract][Full Text] [Related]
2. Excess costs of hospital care associated with neonatal candidemia.
Smith PB; Morgan J; Benjamin JD; Fridkin SK; Sanza LT; Harrison LH; Sofair AN; Huie-White S; Benjamin DK
Pediatr Infect Dis J; 2007 Mar; 26(3):197-200. PubMed ID: 17484214
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
Zaoutis TE; Argon J; Chu J; Berlin JA; Walsh TJ; Feudtner C
Clin Infect Dis; 2005 Nov; 41(9):1232-9. PubMed ID: 16206095
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of community-onset candidemia in Connecticut and Maryland.
Sofair AN; Lyon GM; Huie-White S; Reiss E; Harrison LH; Sanza LT; Arthington-Skaggs BA; Fridkin SK
Clin Infect Dis; 2006 Jul; 43(1):32-9. PubMed ID: 16758415
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
[TBL] [Abstract][Full Text] [Related]
6. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
Kirkland KB; Briggs JP; Trivette SL; Wilkinson WE; Sexton DJ
Infect Control Hosp Epidemiol; 1999 Nov; 20(11):725-30. PubMed ID: 10580621
[TBL] [Abstract][Full Text] [Related]
7. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
8. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies.
Falagas ME; Apostolou KE; Pappas VD
Eur J Clin Microbiol Infect Dis; 2006 Jul; 25(7):419-25. PubMed ID: 16773391
[TBL] [Abstract][Full Text] [Related]
9. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
10. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.
Song X; Srinivasan A; Plaut D; Perl TM
Infect Control Hosp Epidemiol; 2003 Apr; 24(4):251-6. PubMed ID: 12725353
[TBL] [Abstract][Full Text] [Related]
11. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
Odetola FO; Gebremariam A; Freed GL
Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
[TBL] [Abstract][Full Text] [Related]
12. The cost of injury: hospital charges for pregnant trauma patients, 1999 to 2003.
Periyanayagam U; Crandall M
Am J Surg; 2014 Jul; 208(1):130-5. PubMed ID: 24530040
[TBL] [Abstract][Full Text] [Related]
13. Attributable mortality of nosocomial candidemia, revisited.
Gudlaugsson O; Gillespie S; Lee K; Vande Berg J; Hu J; Messer S; Herwaldt L; Pfaller M; Diekema D
Clin Infect Dis; 2003 Nov; 37(9):1172-7. PubMed ID: 14557960
[TBL] [Abstract][Full Text] [Related]
14. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
[TBL] [Abstract][Full Text] [Related]
15. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000.
Shetty SS; Harrison LH; Hajjeh RA; Taylor T; Mirza SA; Schmidt AB; Sanza LT; Shutt KA; Fridkin SK
Pediatr Infect Dis J; 2005 Jul; 24(7):601-4. PubMed ID: 15999000
[TBL] [Abstract][Full Text] [Related]
16. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.
McGarry SA; Engemann JJ; Schmader K; Sexton DJ; Kaye KS
Infect Control Hosp Epidemiol; 2004 Jun; 25(6):461-7. PubMed ID: 15242192
[TBL] [Abstract][Full Text] [Related]
17. Excess mortality, length of stay and cost attributable to candidaemia.
Hassan I; Powell G; Sidhu M; Hart WM; Denning DW
J Infect; 2009 Nov; 59(5):360-5. PubMed ID: 19744519
[TBL] [Abstract][Full Text] [Related]
18. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place.
Pasqualotto AC; de Moraes AB; Zanini RR; Severo LC
Infect Control Hosp Epidemiol; 2007 Jul; 28(7):799-804. PubMed ID: 17564981
[TBL] [Abstract][Full Text] [Related]
19. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
[TBL] [Abstract][Full Text] [Related]
20. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
